Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

HIV/AIDS TESTING - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for HIV/AIDS Testing in US$ Million by the following product segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.The report profiles 63 companies including many key and niche players such as Abbott Laboratories Inc., Abbott Molecular Inc., Adaltis S.r.l., Biomérieux SA, Bio-Rad Laboratories Inc., Calypte Biomedical Corporation, Celera Group, Gen-Probe, Inc., Innogenetics NV, MedMira Laboratories, Inc., Medical Services International Inc., OraSure Technologies Inc., Ortho-Clinical Diagnostics Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-3401
Price : $4500
Companies : 63
Pages : 435
Date : October 2010
Market Data Tables : 140

Complimentary Report Insights:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  HIV/AIDS TESTING (Complete Report) Pages : 435   | $4500
 
  1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.......14 $295  
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2
Data Interpretation & Reporting Level.......2
  
   Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
Definitions.......3
HIV/AIDS Screening Tests.......3
HIV/AIDS Confirmatory Tests.......3
  
   HIV/AIDS Monitoring Tests.......4  
  2. INDUSTRY OVERVIEW........59 $595  
   Recession & Healthcare Industry........5
Impact on Testing Market........5
IVD Market: Growth Despite Recession........5
1$100
   AIDS Testing, Treatment and Services – An Insight........6
Worldwide HIV/AIDS Testing Market – An Analysis........6
1$100
   Regional Analysis........7
Segment Analysis........7
HIV/AIDS Screening........7
1$100
   Confirmatory Test Market........8
HIV/AIDS Monitoring Market........8
Growth Drivers........8
1$100
   Rapid HIV Tests – Vast Growth Potential........9
New HIV Assays to Fuel Growth........9
1$100
   Home Testing to Gain Strength........10
Molecular Diagnostics Register Strong Growth in Blood Screening Markets........10
Ultra-Rapid HIV-screening Tests- A Strong Fight against HIV-Epidemic........10
Emergency Room Testing to Help HIV Diagnosis........10
1$100
   OTC HIV Tests to See The Light?........11
Leading Players........11
1$100
   FDA Approved Rapid Test Kits........12
HIV/AIDs Diagnostics Market Participants – Product Matrix........12
2$200
  3. AIDS: A GLOBAL EPIDEMIC........145 $950  
   AIDS - A Serious Threat........14
Facts & Figures........14
1$100
   Table 1: HIV/AIDS Statistics Worldwide: End-2008 (includes corresponding Graph/Chart)........15

Table 2: Worldwide Living Population Infected with HIV/AIDS (2008-End) (includes corresponding Graph/Chart)........15
1$350
   Table 3: Worldwide HIV & AIDS Incidences (End-2008): Percentage Share Breakdown of Living and Newly Infected Cases by Region (includes corresponding Graph/Chart)........16

Table 4: Worldwide Deaths Due to AIDS (2008-End) (includes corresponding Graph/Chart)........16
1$350
   Table 5: HIV/AIDS Cases in Adults and Children Worldwide: Breakdown by Region-End 2008........17

Table 6: HIV Prevalence (%) in Adults (15-49 years) (includes corresponding Graph/Chart)........17
1$350
   New HIV Infections in Young People........18
Anti-AIDS Therapeutics: A Blessing in Disguise in Developed Countries........18
1$100
  4. UNDERSTANDING THE DISEASE........195 $395  
   Mechanism of Action........191$100
   Symptoms........201$100
   Full-Blown AIDS........211$100
   Transmission of HIV........22
On the Brighter Side........22
HIV Therapy........22
1$100
   The Search Continues........23
Infection Process - Targets for HIV Therapy........23
1$100
  5. DIAGNOSIS OF HIV/AIDS........24   
   Testing: The Basis for AIDS Prevention and Treatment........24
Blood Processing........24
The Earliest Time to Detect Infection........24
1$100
   Testing Plagued by Problems Such As........25
Major Drawbacks of Laboratory Diagnosis of HIV Infections........25
Rapid Tests - Suitable for Developing Countries........25
1$100
  6. HIV TESTS........2615 $950  
   Testing Subject to Strict Rules........26
Diagnostic Tests........26
I. Antibody Tests........26
A. HIV-1 Screening Tests........26
1$100
   Test Methodology........27
a. Enzyme-linked Immunosorbent Assays/Enzyme Immunoassays (ELISA/EIA)........27
1$100
   b. Home AccessHIV-1 test system/Dried Blood Spot........281$100
   c. Rapid Tests........29
Generic Assay Formats in Rapid Test........29
The Dot Blot Rapid Test........29
1$100
   Agglutination Tests........30
Solid Phase Test........30
Immunochromatographic strip (ICS) Tests........30
Rapid Serological Tests Vs. ELISA Tests........30
1$100
   B. HIV-1 Antibody Confirmatory Tests........31
a. The Western Blot Test........31
Commonly Used in Developed Countries........31
1$100
   Interpretation of Results........32
Modified Western Blots........32
b. Indirect Immunofluorescent Antibody Assay (IFA)........32
1$100
   c. Line Immunoassay........33
d. Radioimmunoprecipitation Assay (RIPA)........33
C. HIV-2 Diagnostic Tests and HIV Group “O........33
1$100
   Testing Protocols........34
Types of Antibody Tests Based on Sample........34
i. Traditional Blood Antibody Tests........34
ii. Dried Blood Spot (DBS) Sampling Technique........34
Blood Tests Are Highly Expensive........34
1$100
   iii. Other Alternatives in Samples........35
Oral Testing for HIV........35
Urine Tests........35
II. Viral Identification Assays........35
A. p24 Antigen Test........35
1$100
   B. Qualitative PCR Tests........36
C. Viral Culture........36
Monitoring Tests........36
1$100
   A. Lymphocyte Analysis........37
B. Viral Load Tests........37
1$100
   Indicator of Successful Therapy........38
Levels of CD4 and Viral Load in AIDS........38
C. Drug Resistance Tests........38
Main Types........38
1$100
   i. Genotyping Tests........39
ii. Phenotyping Tests........39
Molecular Diagnostics and Gene Detection Products........39
DNA Probe-Based Products........39
Direct Assays........39
1$100
   Amplification........40
Amplification Methodologies........40
1$100
  7. TECHNOLOGY REVIEW........41   
   PCR: A Promising Development in HIV/AIDS Monitoring Market........41
DNA Probes are Highly Specific and Sensitive........41
OCA-particles Based Detection System-Offers Increased Accuracy........41
Home HIV Tests: Unfolding a New Era of Testing........41
Yet Nascent........41
1$100
   Not Without Share of Objections........42
Home Access: Monopolizing the Home HIV Test Kit Market........42
Drawbacks of Blood-Based Tests........42
1$100
  8. REGULATIONS........43   
   Overview........43
UN’s Testing Policies in Peacekeeping Force........43
Anonymous Versus Confidential Diagnostic Testing for HIV infection in US........43
Regulatory Approval for Rapid HIV Test Kits in US........43
1$100
   HIV Testing - Mandatory in US Blood Banks........44
1$100
  9. NEW PRODUCT APPROVALS & LAUNCHES........453 $295  
   BioMérieux Launches New HIV Test........45
Quest Diagnostics Releases HIV-1 Coreceptor Tropism Test........45
1$100
   Avioq Wins FDA Clearance for HIV-1 Microelisa System........46
FDA Approves Ortho Clinical Diagnostics’ Diagnostic Assay........46
1$100
   FDA Approves Abbott’s HIV Virus Screening Test........47
1$100
  10. PRODUCT INTRODUCTIONS/INNOVATIONS IN RECENT PAST – A PERSPECTIVE BUILDER........485 $395  
   MedMira Secures Approval for Multiplo Triple Test........48
Calypte Launches Aware Messenger™........48
Abbott Launches Advanced Viral Load Test........48
MedMira Launches MiraCare™ Rapid Tests with Extended Shelf Life........48
1$100
   University Researcher Develops Novel HIV/AIDs Antibody Test Kit........49
bioMérieux Introduces VIKIA® HIV 1 / 2 Rapid HIV Test........49
Dr Lal Pathlabs Develops Inexpensive HIV Monitoring Test........49
MedMira to Launch Multiplo™ Rapid HIV/HCV Antibody Test........49
Shanghai Kehua Develops New HIV/AIDS Test Kit for Faster Diagnosis........49
1$100
   INSTI™ HIV Test Kit from bioLytical™ Receives European CE Mark........50
Rockeby Biomed Gains Approval from MOH to Sell OraQuick across Singapore........50
FDA Approves Chembio’s Rapid HIV Tests for Sale in the US........50
MiraWell Whole Blood Rapid HIV Test Receives Approval from China SFDA........50
1$100
   MiraCare Rapid HIV Antibody Test Receives CE Mark........51
Calypte Receives Approval for Marketing Aware Rapid HIV Tests in Kenya........51
FDA Approves Bayer’s Automated HIV Antibody Test Product........51
1$100
   SA Government Approves Marketing of Calypte’s Aware OMT HIV Test Product........52
Calypte Introduces OTC Version of Aware HIV Test in UAE........52
Roche Obtains European Union’s CE Mark for its cobas TaqScreen MPX Test........52
1$100
  11. RECENT INDUSTRY ACTIVITY........536 $495  
   Spartan Collaborates with Cooperative Diagnostics for PCR Testing for HIV/AIDS........53
MedMira Inks Private Label Deal with Swiss Partner........53
1$100
   MedMira Expands Deal with AHD and Forays into Southeast Asian Markets........54
MedMira Bags Supply Contract from PAHO........54
MedMira Seeks Patent for Latest Rapid Test Platform........54
Abbott Attains Supplemental FDA Approval for RealTime HIV- 1 Viral Load Test........54
USCDC Awards Federal Grant to District of Columbia for HIV Testing........54
1$100
   Premier Includes Roche COBAS HIV-1 Monitoring Test in Contract........55
MedMira Receives USAID Approval for Reveal G3 Rapid HIV Test........55
Calypte Biomedical Inks Agreement with Fusion Capital........55
1$100
   Roche Inks Agreement with Clinton Foundation........56
Ortho-Clinical Attains FDA Approval for HIV Test........56
Geneart Awarded Patent for HIV Vaccine........56
Crucell’s Adenovirus Vector Enters Phase I Clinical Studies........56
1$100
   MedMira to Expand Operations in Eastern Europe........57
Calypte Initiates Sale of Aware™ HIV-1/2 OMT Oral Fluid Test in India........57
Calypte Receives Approval for Aware HIV-1/2 OMT Test........57
1$100
   Bundi Opts for SurgiLance Safety Lancet........58
Chembio Diagnostics Receives Sublicense for HIV-2 Patent........58
1$100
  12. CORPORATE ACTIVITY IN RECENT PAST – A PERSPECTIVE BUILDER........5912 $950  
   Calypte Receives USAID Approval........59
Roche’s Latest HIV-1 Test Receives FDA Approval........59
OraQuick ADVANCE Becomes Preferred HIV Test kit in Philadelphia........59
Beckman Coulter Receives Grant........59
1$100
   Oregon Medical Adopts Roche Diagnostics' HIV Test........60
OraSure Inks Agreement with Supply Chain Management System........60
Bio-Rad Enters into Multi-Year Agreements with Quest Diagnostics........60
CytoDyn Pockets Advanced Genetic Technologies........60
1$100
   Aethlon Partners with ImQuest........61
Quest Diagnostics Receives License from Pathway........61
OraSure Inks Agreement with Constella Group........61
LabCorp to Offer Fully Automated Real-Time HIV Test of Roche Diagnostics........61
1$100
   Abbott Receives FDA Approval for RealTime HIV-1 Test........62
Abbott Receives Health Canada Approval........62
Novartis Receives Health Canada Approval........62
Medical Services Completes Trials of VScan Hepatitis C and HIV Test Kit........62
Health Canada Approves Versant 440 Molecular Systems........62
1$100
   OraSure Receives CE Mark for OraQuick ADVANCE HIV Test........63
MedMira Receives Approval for Multiplo HBV/HIV/HCV........63
Roche Diagnostics Partners with ARK Diagnostics........63
Roche’ HIV Viral Load Test Used In Clinical Trials........63
Innogenetics and Bio-Rad Ink Licensing Agreement........63
OraSure Bags Contract From Madagascar Government........63
1$100
   Calypte Receives Approval for Aware(TM) HIV-1/2 OMT Rapid Test........64
Siemens Acquires Bayer Diagnostics........64
Gen-Probe’s HIV Test Receives FDA Approval........64
Bayer Receives FDA Approval for Automated HIV Test........64
Inverness Receives Marketing Rights for Rapid HIV Test........64
Clinton Foundation Inks Agreement with Guava Technologies........64
1$100
   MedMira Inks Distribution Agreement with Voden........65
Roche Bags CE Mark certification........65
Chembio Diagnostics Bags Major Contract........65
Calypte Receives Approval for HIV Test........65
Medical Services Expands Distribution Channel in South Africa........65
1$100
   Rockeby Receives Approval from Singaporean Ministry of Health........66
MedMira Receives SFDA Approval........66
Roche Adopts Primagen’s DFS Technology........66
Calypte and Mineseeker to Supply Aware™ AIDS Test Kit Across Africa........66
OraSure Bags US$6 Million Order to Deliver HIV Test Kits........66
1$100
   Trinity Biotech Enters into Agreement to Deliver Uni- Gold HIV Test Kits to
  PPFA........67
Trinity Biotech Delivers Uni-Gold™ Rapid HIV Test to 340B Prime Vendor Program........67
MedMira Bags Order from Exportrade for MiraWell Rapid HIV Tests........67
1$100
   OraSure Receives Bulk Order for Rapid HIV Tests from CDC........68
MedMira Bags Order from Spree Trading for MiraWell Rapid HIV Tests........68
IRIS Acquires Leucadia with Plans to Introduce HIV & Cancer Testing Products........68
Clindia to Distribute MiraCare Rapid HIV Test in the Netherlands........68
1$100
   MedMira Bags Order from Goodman Medical........69
bioMérieux Bags Contract to Provide Equipment for HIV Viral Load Measurement........69
Novartis Acquires Chiron to Create a New Diagnostics & Vaccines Division........69
Abbott Enters into Agreement with Novation for Supplying OraQuick® ADVANCE™ HIV
  Tests........69
1$100
   Roche Diagnostics Enters into Three-Year Agreement with Premier to Deliver Molecular
  Products........70
MedMira Bags Order to Deliver MiraCare™ HIV Tests Across Europe........70
1$100
  13. FOCUS ON SELECT GLOBAL PLAYERS........715 $395  
   Abbott Laboratories, Inc. (USA)........71
Abbott Molecular, Inc. (USA)........71
Adaltis S.r.l. (Italy)........71
Biomérieux SA (France)........71
1$100
   Bio-Rad Laboratories, Inc. (USA)........72
Calypte Biomedical Corporation (USA)........72
Celera Group (USA)........72
1$100
   Gen-Probe, Inc. (USA)........73
Innogenetics NV (Belgium)........73
MedMira Laboratories, Inc. (Canada)........73
1$100
   Medical Services International Inc. (Canada)........74
OraSure Technologies, Inc. (USA)........74
Ortho-Clinical Diagnostics, Inc. (USA)........74
1$100
   Roche Diagnostics (Switzerland)........75
Siemens Healthcare Diagnostics, Inc. (USA)........75
1$100
  14. GLOBAL MARKET PERSPECTIVE........76   
   Unit Analytics........76
Table 7: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........76
1$350
   Table 8: World Historic Review for HIV/AIDS Testing by Geographic Region – US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........771$350
   Table 9: World 11-Year Perspective for HIV/AIDS Testing by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........781$350
   Table 10: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........791$350
   Table 11: World Historic Review for HIV/AIDS Screening Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........801$350
   Table 12: World 11-Year Perspective for HIV/AIDS Screening Tests by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........811$350
   Table 13: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........821$350
   Table 14: World Historic Review for HIV/AIDS Confirmatory Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........831$350
   Table 15: World 11-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........841$350
   Dollar Analytics........85
Table 16: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........85
1$350
   Table 17: World Historic Review for HIV/AIDS Testing by Geographic Region – US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........861$350
   Table 18: World 11-Year Perspective for HIV/AIDS Testing by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........871$350
   Table 19: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........881$350
   Table 20: World Historic Review for HIV/AIDS Screening Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........891$350
   Table 21: World 11-Year Perspective for HIV/AIDS Screening Tests by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........901$350
   Table 22: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........911$350
   Table 23: World Historic Review for HIV/AIDS Confirmatory Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........921$350
   Table 24: World 11-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........931$350
   Table 25: World Recent Past, Current & Future Analysis for HIV/AIDS Monitoring Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........941$350
   Table 26: World Historic Review for HIV/AIDS Monitoring Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........951$350
   Table 27: World 11-Year Perspective for HIV/AIDS Monitoring Tests by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........96
1$350
  15. THE UNITED STATES........9713 $2450  
   A. Market Analysis........97
Outlook........97
Rapid HIV Tests Display Rapid Growth........97
1$100
   FDA Approved Rapid Test Kits........98
NAT Tests Score High in Blood Banks........98
HIV/AIDS Stats........98
1$100
   Table 28: Percentage of HIV/AIDS Cases in the US, by Gender: 1993-2029 (includes corresponding Graph/Chart)........99

Table 29: AIDS Diagnoses in the US (2005): Breakdown by Ethnic Groups/Race (includes corresponding Graph/Chart)........99
1$350
   Major End-Users of HIV/AIDS Tests........100
HIV Testing Made Mandatory in Blood Banks........100
Home HIV Tests........100
1$100
   Efforts by Organizations........101
FDA Approved HIV/AIDS Tests in the US Market (2006-2009)........101
1$100
   FDA Approved HIV/AIDS Tests in the US market (1998-2004)........1022$200
   Competitive Structure........1041$100
   Historic Market Share Data........105
Table 30: Leading Players in the HIV Diagnostics Market in the US (2005): Percentage Share Breakdown of Value Sales for Abbott Laboratories, Bio-Rad, BioMerieux, Ortho Clinical Diagnostics and Others (includes corresponding Graph/Chart)........105

Table 31: Leading Players in HIV Viral Load Testing Market in the US (2005): Percentage Share Breakdown of Value Sales Roche, Bayer, and Others (includes corresponding Graph/Chart)........105
1$350
   B. Market Analytics........106
Table 32: US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........106
1$350
   Table 33: US Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........107

Table 34: US 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........107
1$350
   Table 35: US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment – HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1081$350
   Table 36: US Historic Review for HIV/AIDS Testing by Product Segment –HIV/ AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........109

Table 37: US 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........109
1$350
  16. CANADA.....1108 $1995  
   A. Market Analysis........110
Outlook........110
AIDS/HIV: Some Facts & Figures........110
1$100
   Table 38: AIDS Cases in Canada by Ethnic Status: 2002 – 2006 (includes corresponding Graph/Chart)........111
HIV Statistics........111
1$350
   Table 39: HIV Statistics for Canada by Exposure Category: 2008 (includes corresponding Graph/Chart)........1121$350
   Table 40: AIDs and Positive HIV Cases in Canada by Age Group: 2006-End (includes corresponding Graph/Chart)........113
HIV Incidence Among Women........113
1$350
   B. Market Analytics........114
Table 41: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........114
1$350
   Table 42: Canadian Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........115

Table 43: Canadian 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........115
1$350
   Table 44: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/ AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1161$350
   Table 45: Canadian Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........117

Table 46: Canadian 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........117
1$350
  17. JAPAN........1184 $950  
   Market Analysis........118
Table 47: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........118
1$350
   Table 48: Japanese Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........119

Table 49: Japanese 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........119
1$350
   Table 50: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1201$350
   Table 51: Japanese Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........121

Table 52: Japanese 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........121
1$350
  18. EUROPE........12216 $3450  
   A. Market Analysis........122
Outlook........122
Regional Analysis........122
Segment Analysis........122
AIDs/HIV Stats – A Review........122
1$100
   Western Europe........123
Table 53: HIV/AIDS Prevalence in Western Europe: Facts and Figures by Country (2007) (includes corresponding Graph/Chart)........123
Central Europe........123
1$350
   Table 54: HIV/AIDS Prevalence in Central Europe: Facts and Figures by Country (2007)........124

Table 55: HIV Diagnosis in Central Europe: Facts and Figures by Country(2006) (includes corresponding Graph/Chart)........124
1$350
   E astern Europe........125
Table 56: HIV/AIDS Prevalence in Eastern Europe: Facts and Figures by Country (2007)........125
1$350
   Table 57: HIV Diagnosis in Eastern Europe: Facts and Figures by Country (2006) (includes corresponding Graph/Chart)........1261$350
   Regulations........127
Antenatal HIV Testing in Europe........127
Finland........127
Germany........127
Luxembourg........127
Sweden........127
1$100
   B. Market Analytics........128
Unit Analytics........128
Table 58: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region – France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........128
1$350
   Table 59: European Historic Review for HIV/AIDS Testing by Geographic Region – France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........1291$350
   Table 60: European 11-Year Perspective for HIV/AIDS Testing by Geographic Region – Percentage Breakdown of Unit Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........1301$350
   Table 61: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........131

Table 62: European Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........131
1$350
   Table 63: European 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........1321$350
   Dollar Analytics........133
Table 64: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region – France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........133
1$350
   Table 65: European Historic Review for HIV/AIDS Testing by Geographic Region – France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........1341$350
   Table 66: European 11-Year Perspective for HIV/AIDS Testing by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, & Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........1351$350
   Table 67: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment – HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1361$350
   Table 68: European Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........137

Table 69: European 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........137
1$350
  18a. FRANCE........1384 $950  
   Market Analysis........138
Table 70: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........138
1$350
   Table 71: French Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........139

Table 72: French 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........139
1$350
   Table 73: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment – HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1401$350
   Table 74: French Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........141

Table 75: French 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........141
1$350
  18b. GERMANY........1424 $950  
   Market Analysis........142
Table 76: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........142
1$350
   Table 77: German Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........143

Table 78: German 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........143
1$350
   Table 79: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/ AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1441$350
   Table 80: German Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........145

Table 81: German 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........145
1$350
  18c. ITALY........1465 $1450  
   A. Market Analysis........146
Outlook........146
Few Facts........146
Table 82: HIV/AIDS Prevalence Rates by Age Group in Italy: End of 2007 (includes corresponding Graph/Chart)........146
1$350
   B. Market Analytics........147
Table 83: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........147
1$350
   Table 84: Italian Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........148

Table 85: Italian 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........148
1$350
   Table 86: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment – HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1491$350
   Table 87: Italian Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........150

Table 88: Italian 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........150
1$350
  18d. THE UNITED KINGDOM........1516 $1450  
   A. Market Analysis........151
Outlook........151
Trends in HIV and AIDS Statistics........151
1$100
   Table 89: HIV Diagnoses in the UK by Exposure Category: 1995 Till June 2007 (includes corresponding Graph/Chart)........152

Table 90: HIV Cases in the UK: Breakdown by Age Group Till June 2009 (includes corresponding Graph/Chart)........152
1$350
   B. Market Analytics........153
Table 91: UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........153
1$350
   Table 92: UK Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........154

Table 93: UK 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........154
1$350
   Table 94: UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1551$350
   Table 95: UK Historic Review for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........156

Table 96: UK 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........156
1$350
  18e. SPAIN........1574 $950  
   Market Analysis........157
Table 97: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........157
1$350
   Table 98: Spanish Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........158

Table 99: Spanish 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........158
1$350
   Table 100: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment – HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1591$350
   Table 101: Spanish Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........160

Table 102: Spanish 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........160
1$350
  18f. REST OF EUROPE........1616 $1450  
   A. Market Analysis........161
Outlook........161
AIDS Review........161
Austria........161
1$100
   Russia........162
Ukraine........162
Other European Countries........162
1$100
   B. Market Analytics........163
Table 103: Rest of Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........163
1$350
   Table 104: Rest of Europe Historic Review for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........164

Table 105: Rest of Europe 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........164
1$350
   Table 106: Rest of Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1651$350
   Table 107: Rest of Europe Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........166

Table 108: Rest of Europe 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........166
1$350
  19. ASIA-PACIFIC....1679 $2450  
   A. Market Analysis........167
Outlook........167
The Next Epicenter for the AIDS Epidemic........167
Table 109: AIDS/HIV Stats in Asia (2008)........167
1$350
   Review of Select Asian Countries........168
Australia........168
Table 110: Number of HIV and AIDs Cases in Australia: Mid-1990s to 2008 (includes corresponding Graph/Chart)........168
1$350
   Table 111: Number of AIDs Cases & Deaths in Australia by Age Group and Gender: End-2008 (includes corresponding Graph/Chart)........169
China........169
AIDs/HIV- A Review........169
1$350
   Efforts to Combat HIV/AIDs........170
India-Rapid Increase in HIV........170
Table 112: Estimated Living Population in India with HIV/AIDS Infection (2007): Breakdown by Group (In ‘000)........170
1$350
   Table 113: HIV/AIDS Cases in India in 2005: Percentage Breakup by Mode of Transmission (includes corresponding Graph/Chart)........171
Thailand........171
HIV Cases on Decline........171
Table 114: Number of Live Persons Infection with HIV in Thailand: 2005-End (includes corresponding Graph/Chart)........171
1$350
   Vietnam........172
B. Market Analytics........172
Table 115: Asia Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........172
1$350
   Table 116: Asia-Pacific Historic Review for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........173

Table 117: Asia Pacific 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........173
1$350
   Table 118: Asia Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1741$350
   Table 119: Asia-Pacific Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........175

Table 120: Asia Pacific 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........175
1$350
  20. LATIN AMERICA........1766 $1950  
   A. Market Analysis........176
Outlook........176
HIV Epidemic in Latin America........176
Table 121: HIV/AIDS Prevalence in Latin America: 2002-2008 (in Millions) (includes corresponding Graph/Chart)........176
1$350
   Table 122: People Living with HIV Infection in Latin America by Country: 2007 (includes corresponding Graph/Chart)........177
Trends and Transmission Modes........177
1$350
   Trends in Antiretroviral Treatment........178
B. Market Analytics........178
Table 123: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........178
1$350
   Table 124: Latin America Historic Review for HIV/AIDS Testing by Product Segment – HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........179

Table 125: Latin America 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........179
1$350
   Table 126: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1801$350
   Table 127: Latin America Historic Review for HIV/AIDS Testing by Product Segment – HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........181

Table 128: Latin America 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........181
1$350
  21. REST OF WORLD........18210 $2450  
   A. Market Analysis........182
Outlook........182
HIV in Africa : Bearing the Brunt of the Epidemic........182
1$100
   Table 129: HIV/AIDS Cases in Africa as of 2007-End: Breakdown By Top 20 Countries (includes corresponding Graph/Chart)........1831$350
   Table 130: HIV/AIDS Prevalence Rate (%) in Sub-Saharan African Countries........1841$350
   Table 131: Adults & Children Deaths Due to AIDS in Africa (2007): Breakdownby Top 10 Countries (includes corresponding Graph/Chart)........185
Sub-Saharan Africa........185
1$350
   Table 132: AIDS/HIV Stats in Sub-Saharan Africa (2008)........186
Southern Africa........186
East, West and Central Africa........186
South Africa – The HIV/AIDS Hub........186
1$350
   Uganda – A Review........187
Caribbean Nations........187
Table 133: AIDS/HIV Stats in the Caribbean Nations (2008)........187
1$350
   Table 134: HIV/AIDS Prevalence in Caribbean Nations Till End of 2007 (includes corresponding Graph/Chart)........188
B. Market Analytics........188
Table 135: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2007 through 2015 (includes corresponding Graph/Chart)........188
1$350
   Table 136: Rest of World Historic Review for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2006 (includes corresponding Graph/Chart)........189

Table 137: Rest of World 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2005, 2010 & 2015........189
1$350
   Table 138: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2007 through 2015 (includes corresponding Graph/Chart)........1901$350
   Table 139: Rest of World Historic Review for HIV/AIDS Testing by Product Segment –HIV/ AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2006 (includes corresponding Graph/Chart)........191

Table 140: Rest of World 11-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........191
1$350
COMPETITION 228$995
  
Total Companies Profiled: 63 (including Divisions/Subsidiaries - 70)

Region/Country                 Players


The United States                 47    
Canada                             5
Europe                            10 
     France                        1
     Germany                       2
     Italy                         1
     Rest of Europe                6
Asia-Pacific (Excluding Japan)     6
Africa                             1
Middle-East                        1
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign